Jing-xiao Xu

Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation

Chuan-Xia Zhang, Dai-jia Huang, Valentin Baloche et al. · Oncogenesis · 2020 · 100 citations · Full text

Medicine, Immunology, Oncology +17

T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer

Huan-he Ni, Huanling Zhang, Lin Li et al. · Journal for ImmunoTherapy of Cancer · 2022 · 77 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer

He Huang, Caiping Nie, Xiufeng Liu et al. · Journal of Clinical Investigation · 2022 · 55 citations · Full text

Medicine, Immunology, Oncology +17

A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients

Yu-Jing Liang, Qiuyan Chen, Jing-xiao Xu et al. · European Journal of Cancer · 2023 · 13 citations

Life Sciences, Immunology, Oncology +10

Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells

Jing-xiao Xu, Rong Zhang, Dai-jia Huang et al. · Microbiology Spectrum · 2023 · 11 citations · Full text

Medicine, Cancer Biology, Oncology +17